Alan M. Levine is Director at Axogen, Inc. (AXGN). They have made 1 open-market trade across 1 company since 2025, most recently 2026-06-19.
CIK 0001766833
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AXGN | 50,893 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-06-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AXGN | SELL | 2025-06-09 | 2025-06-11 | $10.61 | $43K | +0.8% | +18.1% | +63.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.